Harbour Investments’s Definium Therapeutics DFTX Stock Holding History

Harbour Investments’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.4K	Sell	328 -228	-41%	-$5.63K	﹤0.01%	3109
2026 Q1	$10.5K	Buy	+556	New	+$9.44K	﹤0.01%	3240
2025 Q4	–	Sell	-556	Closed	-$6.55K	–	3965
2025 Q3	$6.55K	Hold	556	–	–	﹤0.01%	2873
2025 Q2	$3.61K	Buy	556 +200	+56%	+$1.31K	﹤0.01%	2984
2025 Q1	$2.08K	Hold	356	–	–	﹤0.01%	3078
2024 Q4	$2.48K	Sell	356 -100	-22%	-$688	﹤0.01%	2963
2024 Q3	$2.6K	Hold	456	–	–	﹤0.01%	2849
2024 Q2	$3.29K	Buy	456 +177	+63%	+$1.55K	﹤0.01%	2666
2024 Q1	$2.62K	Buy	279 +179	+179%	+$1.02K	﹤0.01%	2699
2023 Q4	$366	Buy	100 +90	+900%	+$271	﹤0.01%	2969
2023 Q3	$31	Hold	10	–	–	﹤0.01%	2958
2023 Q2	$36	Hold	10	–	–	﹤0.01%	2986
2023 Q1	$32	Hold	10	–	–	﹤0.01%	2965
2022 Q4	$22	Buy	+10	New	+$28	﹤0.01%	2976
2021 Q4	$0	Sell	11 -40	-78%	-$1.28K	﹤0.01%	3283
2021 Q3	$2K	Sell	51 -91	-64%	-$3.93K	﹤0.01%	3335
2021 Q2	$7K	Buy	+142	New	+$7.45K	﹤0.01%	2915

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Harbour Investments's DFTX Position: Q2 2026 in Review

Harbour Investments reduced its Definium Therapeutics (DFTX) stake by 41% in Q2 2026, selling an estimated $5.63K and leaving 328 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3109.

Harbour Investments first reported a position in DFTX in Q2 2021 and has held it in 17 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Harbour Investments held 328 shares of Definium Therapeutics worth $15.4K as of Q2 2026.
Harbour Investments sold 228 Definium Therapeutics shares in Q2 2026, an estimated $5.63K.
Definium Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3109 holding.
Harbour Investments first reported a position in Definium Therapeutics in Q2 2021 and has held it in 17 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.